MyOme, a leading clinical whole-genome testing and polygenic risk modeling (PRS) company, today announced the launch of its Prostate Cancer Integrated Polygenic Risk Scoretm (iPRS) test ? a ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics ...

As artificial intelligence begins to play a more central role in drug discovery, how do researchers and scientists achieve the right mix of AI-driven insights, data integrity, human involvement and ...

This important study describes a deep learning framework that analyzes single-cell RNA data to identify a tumor-agnostic gene signature associated with brain metastases. The identified signature ...

Novartis plans to upfit a 202,000-square-foot purpose-built space in Pathway Triangle, a new advanced manufacturing campus in ...

Siemens Healthineers AG ( OTCPK:SMMNY) Analyst/Investor Day November 17, 2025 8:00 AM EST ...

Discover how transperineal prostate biopsy under local anaesthesia delivers high diagnostic yield safely and without ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the ...

Discover how robotic-assisted lung biopsies are offering hope for earlier cancer detection and potentially saving lives in ...

L ord David Cameron has shared that he was treated for prostate cancer and is now supporting a special screening program for ...

GPs to start inviting the first men to join a landmark trial to make diagnosis earlier, safer and more effective – and cut ...